Mr. Steve Loutskou reports

CANNVAS NAMES DATA PROTECTION OFFICER AND PLANS FOR EXPANSION TO GERMANY

Cannvas Medtech Inc. has appointed Radu Puscasu as data protection officer. With over 14 years of experience, Mr. Puscasu has been heavily involved in creating meaningful customer relationship experiences through secure technology. He has held senior roles at Bell Media, TD Bank Securities (equity derivative solutions and data management services) and Pitney Bowes and has worked with client companies such as Takeda, AstraZenaca, Pfizer and Novartis.

Also, Cannvas intends to expand into Germany, one of the fastest-growing medical cannabis marketplaces in the world. The country has fully embraced medical cannabis as a legitimate, doctor-prescribed, insurance-paid and pharmacy-provided medical and health care product.

"As part of our expansion into Germany and the European Union, I am very pleased to announce the appointment of Radu Puscasu to the role of data protection officer," said Steve Loutskou, chief operating officer, global markets, of Cannvas Medtech. "Data and information security has never been more important, and we are taking the necessary step to ensure total and complete security with our patient-centric life sciences learning platform for the cannabis space. With Germany's potential to become one of the largest consumer of medical cannabis in the world, we have been exploring our market entrance with a number of potential partners. We are leveraging our network built through the attendance of many trade events and conventions, and through our partners Tech West and PUF Ventures, to pursue beneficial partnerships on a global basis."

With significant potential to improve the health and wellness of patients around the world, the Cannvas.me platform will allow for global interaction of patients and consumers to medical practitioner and licensed producers. In January, 2017, Germany fully embraced the medical benefits of cannabis and approved the substance as a legitimate, doctor-prescribed, pharmacy-provided and, perhaps most importantly, insurance-paid pharma product. As the most populous member of the 28-country European Union, Germany's population of 82 million people accounts for 16 per cent of the total population and 28 per cent of the euro area economy and represents a significant market opportunity for Cannvas.

About Cannvas Medtech Inc.

Cannvas Medtech is a leading business technology company within the cannabis space. The company designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry and key business drivers.

We seek Safe Harbor.